Masonic Cancer Center

A Comprehensive Cancer Center designated by the National Cancer Institute

Find a Clinical Trial

Quick Search (by title or disease)
  

Go to Advanced Search for more options.

Clinical Trials Help
Contact our Cancer Information Line nurse with your questions about open or upcoming clinical trials, second opinions, or patient referrals.
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

  Sip Protocol

Masonic Cancer Research Center
ccinfo@umn.edu • 612-624-2620 • 1-888-226-2376

Back to Search Instructions

Protocol No. 2013IS044 Principal Investigator Greeno, Edward
Phase Phase I
Age Group Adult Scope National
Secondary Protocol No. 12-102-13
Title An open-label, parallel-group, multicenter phase I study to investigate the pharmacokinetics of NKTR-102 for injection (Etirinotecan pegol) in patients with advanced or metastatic solid tumors and mild or moderate hepatic impairment (Nektar 12-102-13)
Applicable Disease Sites Any Site
Bladder
Colon
Esophagus
Kidney
Liver
Lung
Pancreas
Stomach
Drugs Involved NKTR-102 (etirinotecan pegol)
Status Open
Participating Institutions Masonic Cancer Center
Treatment Type Treatment
Contact Carrie McCann Phone:612-626-2569
Email:mcca0313@umn.edu
  • ©2013 Regents of the University of Minnesota. All rights reserved.
  • The University of Minnesota is an equal opportunity educator and employer
  • Last modified on